A Full Bayesian Model to Handle Structural Ones and Missingness in Economic Evaluations from Individual-Level Data

01/29/2018
by   Andrea Gabrio, et al.
0

Economic evaluations from individual-level data are an important component of the process of technology appraisal, with a view to informing resource allocation decisions. A critical problem in these analyses is that both effectiveness and cost data typically present some complexity (e.g. non normality, spikes and missingness) that should be addressed using appropriate methods. However, in routine analyses, simple standardised approaches are typically used, possibly leading to biased inferences. We present a general Bayesian framework that can handle the complexity. We show the benefits of using our approach with a motivating example, the MenSS trial, for which there are spikes at one in the effectiveness and missingness in both outcomes. We contrast a set of increasingly complex models and perform sensitivity analysis to assess the robustness of the conclusions to a range of plausible missingness assumptions. This paper highlights the importance of adopting a comprehensive modelling approach to economic evaluations and the strategic advantages of building these complex models within a Bayesian framework.

READ FULL TEXT
research
11/21/2020

A Bayesian framework for patient-level partitioned survival cost-utility analysis

Patient-level health economic data collected alongside clinical trials a...
research
03/18/2022

BCEA: An R Package for Cost-Effectiveness Analysis

We describe in detail how to perform health economic cost-effectiveness ...
research
05/18/2018

A Bayesian Parametric Approach to Handle Missing Longitudinal Outcome Data in Trial-Based Health Economic Evaluations

Trial-based economic evaluations are typically performed on cross-sectio...
research
03/29/2022

Linear mixed models to handle missing at random data in trial-based economic evaluations

Trial-based cost-effectiveness analyses (CEAs) are an important source o...
research
07/27/2020

On the robustness of effectiveness estimation of nonpharmaceutical interventions against COVID-19 transmission

There remains much uncertainty about the relative effectiveness of diffe...
research
05/18/2018

Pitfalls of adjusting for mean baseline utilities/costs in trial-based cost-effectiveness analysis with missing data

Failure to account for baseline utilities/costs imbalance between treatm...
research
11/08/2019

Econophysics deserves a revamping

The paper argues that attracting more economists and adopting a more-pre...

Please sign up or login with your details

Forgot password? Click here to reset